Please wait a minute...
Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology)  2012, Vol. 13 Issue (8): 587-588    DOI: 10.1631/jzus.B1201010
Editorial     
Progress and challenges in the cardiovascular field
Jian-an Wang
Department of Cardiology, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China; Cardiovascular Key Lab of Zhejiang Province, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China
Download:     PDF (0 KB)     
Export: BibTeX | EndNote (RIS)      

Abstract  Despite great achievements in their treatment and prevention in the past few decades, cardiovascular diseases remain the leading cause of human mortality and morbidity all around the world. As estimated by the world health organization (WHO) in 2008, over 17 million people die from cardiovascular diseases every year. It is reported that in China we have around 23 million cardiovascular disease patients, along with a significant disease burden (Zhao and Liu, 2012). Business corporations and non-profit health organizations, physicians and biomedical scientists are making great progress in preventing and treating cardiovascular diseases. Due to the globalization of information technology, we are able to access the latest progress in the biomedical field, or look back to the achievements of past decades. However, there are still some ways to go before our guidelines or expert consensus can be used to benefit patients (Huo, 2010). Moreover, numerous new diagnostic techniques and therapeutic methods (including drugs, devices, biomedical materials, and surgical operations) are created every year, making it more and more difficult for physicians to make the optimal choice for patients (Wang, 2010). Therefore, it is of vital importance to introduce, interpret, discuss and summarize information on cardiovascular diseases.

Key wordsCardiovascular diseases      Progress      Qianjiang International Cardiovascular Congress (QICC)     
Received: 19 July 2012      Published: 01 August 2012
CLC:  R54  
Cite this article:

Jian-an Wang. Progress and challenges in the cardiovascular field. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2012, 13(8): 587-588.

URL:

http://www.zjujournals.com/xueshu/zjus-b/10.1631/jzus.B1201010     OR     http://www.zjujournals.com/xueshu/zjus-b/Y2012/V13/I8/587

[1] Zeng-hui Cheng, Yu-xin Shi, Min Yuan, Dan Xiong, Jiang-hua Zheng, Zhi-yong Zhang. Chemokines and their receptors in lung cancer progression and metastasis[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2016, 17(5): 342-351.
[2] Jian-an Wang, Guest-Chief Editor , Chairman of Qianjiang International Cardiovascular Congress . Advances in cardiovascular disease: how far is the summit?[J]. Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology), 2010, 11(8): 547-547.